Skip to main content
. Author manuscript; available in PMC: 2019 Jun 13.
Published in final edited form as: Lancet. 2016 May 22;388(10041):294–306. doi: 10.1016/S0140-6736(16)30448-2

Figure 1. Treated end-stage kidney disease incidence and prevalence by country in 2013.

Figure 1

End-stage kidney disease (ESKD) incidence and prevalence calculated for patients using either maintenance dialysis or a kidney transplant for ESKD. Countries listed in order of lowest to highest incidence within each region. (A) Central and eastern Europe: Russia, Estonia, Bosnia and Herzegovina, Poland, Slovenia, Romania, Serbia, Croatia, Czech Republic, and Hungary; Nordic countries: Iceland, Finland, Norway, Sweden, and Denmark; and western Europe: Ireland, Scotland, UK (excluding Scotland), Netherlands, Spain, Austria, France, Belgium (French speaking), Belgium (Dutch speaking), Greece, and Portugal. (B) Eastern and southeastern Asia (gross national income <US$25 000): Bangladesh, Philippines, Indonesia, Thailand, and Malaysia; eastern and southeastern Asia (gross national income ≥$25 000): Hong Kong, South Korea, Japan, Singapore, and Taiwan; the Middle East: Iran, Qatar, Oman, Saudi Arabia, and Israel; South America: Argentina, Uruguay, Brazil, and Chile; North America: Canada, USA, and Mexico (Jalisco). pmp=per million population. Data are from the US Renal Data System.2